Trading SGMO to $1.9

NASDAQ:SGMO   Sangamo Therapeutics, Inc.
Based on 7 Wall Street analysts offering 12 month price targets for Sangamo Biosciences in the last 3 months. The average price target is $8.20 with a high forecast of $16.00 and a low forecast of $1.50. The average price target represents a 443.05% change from the last price of $1.51.


The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.